Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Clay was most recently Senior Vice President, Global Project Delivery at Fortrea.
February 24, 2026
By: Patrick Lavery
Content Marketing Editor
Caidya is naming Michael Clay its new Chief Operating Officer (COO). As a global, mid-sized contract research organization (CRO), Caidya focuses on accelerating clinical development for biopharmaceutical companies.
For Caidya, Clay will lead the CRO’s global operational delivery, client engagement model, and execution strategy. The company says this approach will further strengthen its ability to serve sponsors in the U.S., Europe, and Asia-Pacific.
It is in the last of these regions where Clay’s experience may prove most helpful to Caidya. A press release announcing his appointment said he has extensive leadership experience across Asia-Pacific. Caidya CEO Barbara Lopez Kunz noted this highlight on Clay’s resume.
“Mike’s leadership strengthens one of our most important differentiators—our ability to combine global reach with regional expertise,” Lopez Kunz said. “His deep understanding of site engagement, global execution, and sponsor partnership will help us scale.”
And this will be done, Lopez Kunz said, while preserving “the agility, accountability, and transparency our clients value.”
In the release, Caidya singled out China as “an increasingly vital region” for innovation in biotech development and patient access.
“I’m excited to join Caidya at a time when global clinical development is becoming more interconnected and complex,” Clay said. “Caidya is strategically positioned to help sponsors accelerate programs while maintaining quality and patient focus.”
To be more specific about Clay’s background, he comes to Caidya after a most recent stint at Fortrea. There, Clay served as Senior Vice President, Global Product Delivery, and oversaw more than 500 clinical trials.
He has also served as COO and in other senior operations roles at CROs earlier in his career.
This is not the only recent personnel move for Caidya. The company has also added, among others, Edward Dow, MD, as oncology and hematology subject matter expert. Additionally, Mario Bautista was named head of Business Development throughout Europe.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !